The drug regulatory body of India, DCGI is waiting for the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approval to AstraZeneca & Oxford’s COVID19 Vaccine, before giving a nod for Emergency Use Authorisation to its Indian counterpart developed by Serum Institute of India (SII) . It’s expected for British- Sweden giant drugmaker AstraZeneca in the UK to get authorization at any time, Sources to The Medically Speaking team
In recent years, India has made significant strides in the fight against cancer, with an…
As we age, our cognitive abilities naturally decline, but diet has emerged as a key…
In a significant move toward revolutionizing patient care, a panel discussion on Artificial Intelligence (AI)-based…
Breast cancer remains one of the leading causes of cancer-related deaths among women worldwide. Early…
Airport Proximity: Can living near an airport increase your risk of a heart attack? A…
Antimicrobial resistance (AMR), the ability of bacteria, fungi, and parasites to resist the effects of…